Characterization, pharmacokinetics, tissue distribution and antitumor activity of honokiol submicron lipid emulsions in tumor-burdened mice

Pharmazie

Volumn 68, Issue 1, 2013, Pages 41-46

  Zheng, Jiaxin ^a   Tang, Yujie ^a   Sun, Moran ^a   Zhao, Yuanyuan ^a   Li, Qiang ^a   Zhou, Jie ^a   Wang, Yanzhi ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HONOKIOL; LIPID EMULSION; ANTINEOPLASTIC AGENT; BIPHENYL DERIVATIVE; LIGNAN; SOYBEAN OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG HALF LIFE; MOUSE; NONHUMAN; OSMOLALITY; PARTICLE SIZE; PH; PLASMA CLEARANCE; SARCOMA; TISSUE DISTRIBUTION; TUMOR GROWTH; TUMOR VOLUME; ZETA POTENTIAL; ANIMAL; AREA UNDER THE CURVE; DRUG FORMULATION; DRUG STABILITY; ELECTROCHEMISTRY; EMULSION; EXPERIMENTAL NEOPLASM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; OSMOLARITY; REPRODUCIBILITY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; DRUG STABILITY; ELECTROCHEMISTRY; EMULSIONS; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRAVENOUS; LIGNANS; MICE; NEOPLASMS, EXPERIMENTAL; OSMOLAR CONCENTRATION; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; SOYBEAN OIL; TISSUE DISTRIBUTION;

MLCS; MLOWN;

EID: 84875792418     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.2062     Document Type: Article

References (39)

1. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell P, Govindarajan B (2003) Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278: 1-7.
2. Böhmdorfer M, Maier-Salamon A, Taferner B, Reznicek G, Thalhammer T, Hering S, Hüfner A, Schühly W, Jäger W (2011) In vitro metabolism and disposition of honokiol in rat and human livers. J Pharm Sci 100: 3506-3516.
3. Chen LJ, Zhang Q, Yang GL, Fan LY, Tang J, Garrard I, Ignatova S, Fisher D, Sutherland IA (2007) Rapid purification and scale-up of honokiol and magnolol using high-capacity high-speed counter-current chromatography. J Chromatogr A 1142: 115-122.
4. Gabizon AA (1992) Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52: 891-896.
5. Ganta S, Paxton JW, Baguley BC, Garg S (2008) Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion. Int J Pharm 360: 115-121.
6. Gong CY, Shi S, Wang XH, Wang YJ, Fu SZ, Dong PW, Chen LJ, Zhao X,Wei YQ, Qian ZR (2009) Novel composite drug delivery system for honokiol delivery: Self-assembled poly(ethylene glycol)-poly(ε-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly (ethylene glycol)-poly (ε-caprolactone)-poly (ethylene glycol) hydrogel. J Phys Chem 113: 10183-10188.
7. Gou ML, Gong CY, Zhang J, Wang XH, Wang XH, Gu YC, Guo G, Chen LJ, Luo F, Zhao X, Wei YQ, Qian ZR (2010) Polymeric matrix for drug delivery: Honokiol-loaded PCL-PEG-PCL nanoparticles in PEG-PCLPEG thermosensitive hydrogel. J Biomed Mater Res A 93A: 219-226.
8. 1 transcriptional activity. Mol Cancer Ther 6: 86-95.
9. Haraguchi H, Ishikawa H, Shirataki N, Fukuda A (1997) Antiperoxidative activity of neolignans from Magnolia obovata. J Pharm Pharmacol 49: 209-212.
10. Kay N, Bone N, Battle T, FrankD(2003)Arecombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells. Leukemia Res 27: 859-863.
11. Komatsu H, Kitajima A, Okada S (1995) Phamaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy. Chem Pham Bull 43: 1412-1415.
12. Kuribara H, Kishi E, Kimura M, Weintraub S, Maruyama Y (2000) Comparative assessment of the anxiolytic-like activities of honokiol and derivatives. Pharmacol Biochem Behav 67: 597-601.
13. Levy MY, Langerman L, Gottschalk-Sabag S, Simon B (1989) Side-effect evaluation of a new diazepam formulation: venous sequela reduction following intravenous (i.v.) injection of a diazepam emulsion in rabbits. Pharm Res 6: 510-516.
14. Levy MY, Schutze W, Fuher C, Benita S (1994) Characterization of diazepam submicron emulsion interface: role of oleic acid. J Microencapsul 11: 79-92.
15. Li XY, Guo QF, Zheng XL, Kong XY, Shi S, Chen LJ, Zhao X, Wei YQ, Qian ZR (2009) Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery. Drug Deliv 16: 160-166.
16. Lin JW, Chen JT, Hong CY, Lin YL,Wang KT, Yao CJ, Lai GM, Chen RM (2012) Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway. Neuro Oncol 14: 302-314.
17. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK (2003) The antiinflammatory effect of honokiol on neutrophils: Mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 475: 19-27.
18. Lundberg BB (1994) Preparation of drug-carrier emulsions stabilized with phospha-tidylcholine-surfactant mixtures. J Pharm Sci 83: 72-75.
19. Mager DE (2006) Quantitative structure-pharmacokinetic/pharmacodynamic relationships. Adv Drug Deliv Rev 58: 1326-1356.
20. Pan J, LouW, Chen L, Liu X (2002) The effect of dipyridamole and adenosine on pulmonary fibrosis in mice. Chin J Tuberc Respir Dis 25: 173-175.
21. Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2: 3-14.
22. Pinnamaneni S, Das NG, Das SK (2003) Comparison of oil-in-water emulsions manufactured by microfluidization and homogenization. Pharmazie 58: 554-558.
23. Ponnurangam S, Mammen JM, Ramalingam S, He Z, Zhang Y, Umar S, Subramaniam D, Anant S (2012) Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Mol Cancer Ther 11: 963-972.
24. Pyo MK, Lee Y, Yun-Choi HS (2002) Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata. Arch Pharm Res 25: 325-328.
25. Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G (2012) Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. J Cell Physiol 227: 2184-2195.
26. Shibata H, Saito H, Yomota C, Kawanishi T (2009) Pharmaceutical quality evaluation of lipid emulsions containing PGE1: Alteration in the number of large particles in infusion solutions. Int J Pharm 378: 167-176.
27. Singh T, Katiyar SK (2011) Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2. Int J Oncol 38: 769-776.
28. Takino T, Konishi K, Takakura Y, Hashida M (1994) Long circulating emulsion carrier system for highly lipophilic drugs. Biol Pharm Bull 17: 121-125.
29. Venkateswarlu V, Patlolla RR (2001) Lipid microspheres as drug delivery systems. Ind J Pharm Sci 63: 450-458.
30. Wang T, Chen F, Chen Z, Wu YF, Xu XL, Zheng S, Hu X (2004) Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 10: 5-8.
31. Wang YZ, Deng YH, Mao SR, Jin SX,Wang J, Bi DZ (2005) Characterization and body distribution of β-elemene solid lipid nanoparticles (SLN). Drug Dev Ind Pharm 31: 769-778.
32. Wang XH, Deng LY, Cai LL, Zhang XY, Zheng H, Deng CY, Duan XM, Zhao X, Wei YQ, Chen LJ (2011a) Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β- cyclodextrin-in-liposome. J Pharm Sci 100: 3357-3364.
33. Wang XH, Cai LL, Zhang X, Deng L, Zheng H, Deng CY,Wen JL, Zhao X, Wei YQ, Chen LJ (2011b) Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol. Int J Pharm 410: 169-174.
34. Washington C (1990) The electrokinetic properties of phospholipidstabilized fat emulsions. Interdroplet potentials and stability ratios in monovalent electrolytes. Int J Pharm 64: 67-73.
35. Yang SE, Hsieh MT, Tsai TH, Hsu SL (2002) Down-modulation of Bcl- XL, release of cytochrome c and sequential activation of caspases duringhonokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol 63: 1641-1651.
36. Yue PF, Lu XY, Zhang ZZ, Yuan HL, Zhu WF, Zheng Q, Yang M (2009) The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion. AAPS PharmSciTech 10: 376-383.
37. Zhang J, Qian Z,GuY(2005) In vivo anti-tumor efficacy of docetaxel-loaded thermally responsive nanohydrogel. Nanotechnology 32: 51-56.
38. Zhao YX, LiangWQ,WangY, LiuDX(2011) Cationic submicron emulsions overcome multidrug resistance in SGC7901/VCR cells. Pharmazie 66: 130-135.
39. Zheng XL, Kan BK, Gou ML, Fu SZ, Zhang J, Men K, Chen LJ, Luo F, Zhao YL, Zhao X,Wei YQ, Qian ZR (2010) Preparation of MPEG-PLA nanoparticle for honokiol delivery in vitro. Int J Pharm 386: 262-267.